MedTrace Logo

Psychosocial Treatment of Depression in Parkinson's Disease

NCT00853346 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-11-16

No results posted yet for this study

Summary

The purpose of the study is to examine the effects of a form of talk therapy called cognitive behavior therapy (CBT) in the treatment of major depression in individuals with Parkinson's disease (PD).

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy

12 weeks of Cognitive Behavioral Therapy designed for adults with Parkinson's Disease and comorbid Depression

BEHAVIORAL

Cognitive Behavioral Therapy

12 weeks of Cognitive Behavioral Therapy designed for adults with Parkinson's Disease and comorbid Depression

Sponsors & Collaborators

Principal Investigators

  • Amy Farabaugh, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00853346 on ClinicalTrials.gov